Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

BACKGROUND: According to new diagnostic guidelines for Alzheimer’s disease (AD), biomarkers enable estimation of the individual likelihood of underlying AD pathophysiology and the associated risk of progression to AD dementia for patients with mild cognitive impairment (MCI). Nonetheless, how confli...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Alzheimers Res Ther
Hoofdauteurs: Alexopoulos, Panagiotis, Werle, Lukas, Roesler, Jennifer, Thierjung, Nathalie, Gleixner, Lena Sophie, Yakushev, Igor, Laskaris, Nikolaos, Wagenpfeil, Stefan, Gourzis, Philippos, Kurz, Alexander, Perneczky, Robert
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146856/
https://ncbi.nlm.nih.gov/pubmed/27931251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-016-0220-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items